EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The polyamine transporter ATP13A3 mediates difluoromethylornithine‐induced polyamine uptake in neuroblastoma

Mujahid Azfar iD, Weiman Gao, Chris Van den Haute iD, Lin Xiao, Mawar Karsa iD, Ruby Pandher, Ayu Karsa, Dayna Spurling iD, Emma Ronca iD, Angelika Bongers, Xinyi Guo, Chelsea Mayoh iD und 8 weitere

Molecular Oncology · 2025

DOI: 10.1002/1878-0261.13789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Mujahid Azfar und 19 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Belgium. Hauptthemen laut MEDLINE: Neuroblastoma, Polyamines, Eflornithine, Adenosine Triphosphatases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: C1 KU Leuven Research grant InterAction, Fonds Wetenschappelijk Onderzoek, The Kids' Cancer Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High‐risk neuroblastomas, often associated with MYCN protooncogene amplification, are addicted to polyamines, small polycations vital for cellular functioning. We have previously shown that neuroblastoma cells increase polyamine uptake when exposed to the polyamine biosynthesis inhibitor difluoromethylornithine (DFMO), and this mechanism is thought to limit the efficacy of the drug in clinical trials. This finding resulted in the clinical development of polyamine transport inhibitors, including AMXT 1501, which is presently under clinical investigation in combination with DFMO. However, the mechanisms and transporters involved in DFMO‐induced polyamine uptake are unknown. Here, we report that knockdown of ATPase 13A3 ( ATP13A3 ), a member of the P5B‐ATPase polyamine transporter family, limited basal and DFMO‐induced polyamine uptake, attenuated MYCN ‐amplified and non‐ MYCN ‐amplified neuroblastoma cell growth, and potentiated the inhibitory effects of DFMO. Conversely, overexpression of ATP13A3 in neuroblastoma cells increased polyamine uptake, which was inhibited by AMXT 1501, highlighting ATP13A3 as a key target of the drug. An association between high ATP13A3 expression and poor survival in neuroblastoma further supports a role of this transporter in neuroblastoma progression. Thus, this study identified ATP13A3 as a critical regulator of basal and DFMO‐induced polyamine uptake and a novel therapeutic target for neuroblastoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaPolyaminesEflornithineAdenosine TriphosphatasesHumansCell Line, TumorBiological TransportCell Proliferation

Stichwörter der Autor:innen

AMXT 1501ATP13A3DFMOneuroblastomapolyamine depletionpolyamine transport inhibitor

Substanzen

PolyaminesEflornithineAdenosine Triphosphatases

Autor:innen und Institutionen

  • Laboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Belgium.
  • Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia.
  • School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Australia.
  • Group for Neurobiology and Gene Therapy, KU Leuven, Belgium.
  • Leuven Viral Vector Core, KU Leuven, Belgium.
  • Aminex Therapeutics, Aminex Therapeutics Inc., Kirkland, WA, USA.

ORCID-Profile: Mujahid Azfar, Chris Van den Haute, Mawar Karsa, Dayna Spurling, Emma Ronca, Chelsea Mayoh, Youri Fayt, Arthur Schoofs, Steven H L Verhelst, Murray D Norris, Michelle Haber, Peter Vangheluwe, Klaartje Somers

Förderung

  • C1 KU Leuven Research grant InterAction
  • Fonds Wetenschappelijk Onderzoek
  • The Kids' Cancer Project
  • Cancer Australia
  • Kids' Cancer Project

Zitieren

APA

Azfar, M., Gao, W., Van den Haute, C., Xiao, L., Karsa, M., Pandher, R., Karsa, A., Spurling, D., Ronca, E., Bongers, A., Guo, X., Mayoh, C., Fayt, Y., Schoofs, A., Burns, M. R., Verhelst, S. H. L., Norris, M. D., Haber, M., Vangheluwe, P., & Somers, K. (2025). The polyamine transporter ATP13A3 mediates difluoromethylornithine‐induced polyamine uptake in neuroblastoma. Molecular Oncology. https://doi.org/10.1002/1878-0261.13789

Vancouver

Azfar M, Gao W, Van den Haute C, Xiao L, Karsa M, Pandher R, et al. The polyamine transporter ATP13A3 mediates difluoromethylornithine‐induced polyamine uptake in neuroblastoma. Molecular Oncology. 2025. doi:10.1002/1878-0261.13789

BibTeX
@article{Azfar2025,
  author = {Azfar, Mujahid and Gao, Weiman and Van den Haute, Chris and Xiao, Lin and Karsa, Mawar and Pandher, Ruby and Karsa, Ayu and Spurling, Dayna and Ronca, Emma and Bongers, Angelika and Guo, Xinyi and Mayoh, Chelsea and Fayt, Youri and Schoofs, Arthur and Burns, Mark R and Verhelst, Steven H L and Norris, Murray D and Haber, Michelle and Vangheluwe, Peter and Somers, Klaartje},
  title = {The polyamine transporter ATP13A3 mediates difluoromethylornithine‐induced polyamine uptake in neuroblastoma},
  journal = {Molecular Oncology},
  year = {2025},
  doi = {10.1002/1878-0261.13789}
}
Kostenlos starten →